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Introduction
Free radicals may play an important role in the causation and
complication of diabetes mellitus. The increased oxidative stress
and accompanying decrease in antioxidants may be related to
the causation of diabetes (1). In diabetes mellitus, alterations in
the endogenous free radical scavenging defense mechanisms
may lead to ineffective scavenging of reactive oxygen species,
resulting in oxidative damage and tissue injury (2). It has been
proposed that streptozotocin acts as a diabetogenic owing to its
ability to destroy pancreatic  -islet cells, possibly by a free
radical mechanism. The level of lipid peroxidation in cells is
controlled by various cellular defense mechanisms consisting of
enzymatic and nonenzymatic scavenger systems (3,4), the levels
of which are altered in diabetes (5).
Coscinium fenestratum Colebr. (Menispermaceae),
commonly known as tree turmeric, grows widely in the
Western Ghats (India) and Sri Lanka. The plant has been
mainly used for treating diabetes mellitus in the traditional
Ayurvedic and Siddha systems of medicine (6). The stem
contains berberine, ceryl alcohol, hentriacontane, sitosterol,
palmitic acid, oleic acid and saponin, together with some
resinous material (7). Isolation of tertiary alkaloids, berlam-
bine, dihydroberlambine and noroxyhydrastinine from the
roots has been reported (8). The stem is used for dyspepsia,
and as a febrifuge. Its hypotensive (9) and hepatoprotec-
tive (10) actions have also been reported. An earlier study
carried out by the authors established the significant
antidiabetic activity of C. fenestratum (11). In the present
investigation we attempted to investigate further the alco-
holic stem extract of C. fenestratum for its antioxidant
status and its effect on key enzymes of carbohydrate
metabolism in streptozotocin and nicotinamide induced type
2 diabetic rats.
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Chemicals and Instruments Used
The following chemicals were used for the study: glucose-
6-phosphate dehydrogenase, glucose-6-phosphate, lactate
dehydrogenase, streptozotocin (Sigma Aldrich Co., Germany);
ascorbic acid, meta phosphoric acid, O-phosphoric acid,
magnesium chloride, EDTA, sodium citrate (NICE Chemicals
Pvt. Ltd, Cochin, India); phenazine methosulfate, nitroblue
tetrazolium chloride, NADH, NADPH, ATP, glutathione, 5, 5 
dithio nitro bis benzoic acid, tocopherol (Himedia Laboratories
Ltd, Mumbai, India); disodium hydrogen phosphate, potassium
hydrogen phosphate (E. Merck India Ltd, Mumbai, India);
2,4 dinitro phenylhydrazine (Sarabhai M. Chemicals, Baroda,
India); sodium pyruvate (S.D. fine-chem Ltd, Mumbai, India);
Tris buffer (SISCO Research Laboratories Ltd, Mumbai,
India); sodium pyro phosphate (Thomas Baker Chemicals Ltd,
Mumbai, India); nicotinamide (Qualigens Fine Chemicals, a
division of Glaxo, Mumbai, India).
A UV spectrophotometer (Shimadazu 160 IPC), homogenizer,
centrifuge and pH meter were the instruments used for the study.
Albino Rats
Healthy adult male Wistar albino rats weighing ~250–300 g
were used. Rats were housed in polypropylene cages, main-
tained under standard conditions (12 h light/12 h dark cycle;
25   3 C; 35–60% humidity), and were fed with a standard rat
pellet diet (Hindustan Lever Ltd, Mumbai, India) and water ad
libitum. The study was approved by the Institutional Animal
Ethical Committee of Kasturba Medical College, Manipal,
India (IAEC/KMC/03/2003-04).
Plant Material
The C. fenestratum plant material, purchased from Jogappa
Shanbag Ayurvedic Store, Udupi, Karnataka, India during
August 2003, was authenticated by Dr Gopalakrishna Bhat,
Professor, Department of Botany, Poorna Prajna College,
Udupi, Karnataka, India. A voucher specimen (PP 526) has
been deposited at the Department of Pharmacognosy, Manipal
College of Pharmaceutical Sciences, Manipal, India.
Preparation of Alcoholic Stem Extract
Approximately 160 g of the stem powder was placed in a soxh-
let extractor and extracted with ethanol for 72 h. The solvent
was recovered by distillation in vacuo, and the residue (yield
18 g), stored in the desiccator, was used for subsequent
experiments (12,13).
Induction of Experimental Diabetes
An rat model of type 2 diabetes mellitus (non-insulin
dependent diabetes mellitus, NIDDM) was induced (14) in
overnight-fasted rats by a single intraperitoneal injection of
60 mg kg 1 streptozotocin 15 min after the intraperitoneal
administration of 120 mg kg 1 nicotinamide. Hyperglycemia
was confirmed by elevated blood glucose levels determined
at 72 h and then on day 7 after injection. Only rats confirmed
to have permanent NIDDM were used for the antidiabetic
study (15).
Experimental Design
Rats were divided into four groups (n   6): normal rats
administered with 2% gum acacia solution, diabetic rats
administered with 2% gum acacia solution, diabetic rats admin-
istered with C. fenestratum alcoholic extract 250 mg kg 1 and
diabetic rats administered with C. fenestratum alcoholic extract
500 mg kg 1, respectively, for 12 days orally (16).
Sample Collection
Blood Sample
At the end of day 12, blood samples were collected under light
ether anesthesia retro-orbitally from the inner canthus of the eye
using capillary tubes (Micro Hematocrit Capillaries, Mucaps).
Blood was collected in fresh vials containing anticoagulant, and
serum was separated in a centrifuge at 2000 r.p.m. for 2 min.
Collection of Organs
Rats were euthanized using an overdose of intraperitoneal
anesthesia, and tissue samples collected for assessing the
following parameters.
Estimation of Enzymes in Carbohydrate Metabolism
The following parameters were evaluated.
Hexokinase (EC 2.7.1.1)
The hexokinase assay is based on the reduction of NAD 
through a coupled reaction with glucose-6-phosphate dehydro-
genase. The excised liver tissue homogenate was prepared in
saline. To 0.1 ml of homogenate were added 2.28 ml of Tris
(200 mmol l 1)–MgCl2 buffer (20 mol l 1), pH 8, 0.5 ml of
0.67 M glucose, 0.1 ml of 16 mM ATP, 0.1 ml of 6.8 mM NAD
and 0.01 ml of 300 U ml 1 glucose-6-phospate dehydrogenase.
The solution was mixed thoroughly, and the absorbance was
measured at 340 nm (17).
Glucose-6-Phosphate Dehydrogenase (EC 1.1.1.49)
The measure of glucose-6-phosphate dehydrogenase activity is
the rate of increase in absorbance. Addition of maleimide
inhibits oxidation of reaction products by 6-phospho glucono-
lactone. Liver tissue was excised and rinsed with saline
solution and the homogenate prepared in saline solution. To
0.02 ml of homogenate were added 0.6 ml of distilled water,
0.1 ml of 3.8 mmol l 1 NADP, 0.1 ml of 0.5 mol l 1 Tris buffer
(pH 7.5), 0.1 ml of 0.63 mol l 1 MgCl2 and 0.1 ml of 33 mol
l 1 glucose-6-phosphate. Then ~0.5 mg of maleimide was
added, with gentle mixing to dissolve the maleimide. The
absorbance was measured at 339 nm. One unit of enzyme
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tion of 1  M of NADP per minute (18).
Lactate Dehydrogenase (EC 1.1.1.27)
Lactate dehydrogenase catalyzes the conversion of L-lactate to
pyruvate with simultaneous reduction and oxidation of NAD
to NADH. Change in absorbance with time as a result of
converting NAD to NADH is directly proportional to LDH
activity. The liver and kidney homogenate was prepared in
saline. To 0.05 ml of tissue homogenate was added 2.5 ml of
Tris (81.3 mmol, pH 7.2)/NaCl (203.3 mmol)/NADH
0.244 mmol l 1), and the solution was mixed thoroughly. To
this solution was added 0.5 ml of Tris (81.3 mmol, pH
7.2)/NaCl (203.3 mmol)/pyruvate (9.76 mmol l 1). The
solution was mixed well and the absorbance measured at
339 nm (19).
Glucose-6-Phosphatase (EC 3.1.3.9)
Glucose-6-phosphatase catalyzes the conversion of glucose-6-
phosphate to glucose. The liver was homogenized in ice-cold
sucrose (250 mM) solution. To 0.1 ml of sucrose/EDTA buffer
were added 0.1 ml of glucose-6-phosphate (100 mM), 0.1 ml
of imidazole buffer (100 mM, pH 6.5) and 0.1 ml of
homogenate, with thorough mixing. The tubes were incubated
at 37  C for 15 min. The enzymatic activity was terminated by
the addition of 2 ml of TCA/ascorbate (10%/2%, w/v), and the
solution was centrifuged at 3000 r.p.m. for 10 min. To 1 ml
of clear supernatant were added 0.5 ml of ammonium molyb-
date (1%, w/v) and 1 ml of sodium citrate (2%, w/v). The
absorbance was measured at 700 nm. The enzyme activity was
expressed as unit per gram per minute in tissue (20).
Alanine Amino Transferase (EC 2.6.1.2)
Alanine amino transferase (ALT) catalyzes the transamination
of  L-alanine to 2-oxo glutarate, forming a glutamate and a
pyruvate. The pyruvate formed is reduced to lactate by lactate
dehydrogenase with simultaneous oxidation of reduced
NADH to NAD. The change in absorbance with time as a
result of the conversion of NADH to NAD is directly propor-
tional to the ALT activity. The kidney homogenate was
prepared in liver homogenate. To 0.2 ml homogenate were
added 2.3 ml L-alanine (610 mmol) in Tris buffer (0.10 mol l 1,
pH 7.15), 0.1 ml of NADH (4.2 mmol l 1), 0.1 ml of pyridoxal
6 phosphate (3.4 mmol l 1) and 0.1 ml of lactate dehydroge-
nase 72 000 U l 1. The reaction was initiated by the addition
of 0.2 ml of 2-oxo glutarate solution. The absorbance was
measured at 339 nm (21).
Urea and Creatinine
Serum urea level was determined using a Urease enzyme kit
modified Berthlot method (Agappe Diagnostics,Thane, India).
The creatinine level in serum was estimated using the alkaline
picrate-modified Jaffe’s method with a creatinine kit (Agappe
Diagnostics).
Estimation of Antioxidant Parameters
Enzymatic antioxidants [glutathione synthetase and glutathione
peroxidase (22), catalase (EC 1.11.1.6) (23,24), peroxidase
(EC 1.11.1.7) (25), superoxide dismutase (EC 1.15.1.1) (26)]
and nonenzymatic antioxidants [ceruloplasmin (27), tocopherol
(28) and ascorbic acid (29)] were determined. The protein
content in the tissue homogenate was estimated following the
standard methodology (30).
Statistical Analysis
Data were statistically evaluated using one-way ANOVA, fol-
lowed by a post hoc Scheffe’s test using the SPSS computer
software, version 7.5. The values were considered significant
when P   0.05.
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Figure 1. Alcoholic extract of C. fenestratum significantly increases hexokinase
levels in diabetic rats. Each value represents mean   SE, n   6; a, statistical
significance versus control (P   0.05); b, statistical significance versus
normal (P   0.05); U,  mol reduction of NAD  per minute.
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Figure 2. Alcoholic extract of C. fenestratum significantly increases glucose-
6-phosphate dehydrogenase levels in diabetic rats. Each value represents
mean   SE, n   6; a, statistical significance versus control (P   0.05); b,
statistical significance versus normal (P   0.05); U,  mol conversion of NAD
to NADH per minute.
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Carbohydrate Metabolism
The activities of different key enzymes (hexokinase, glucose-
6-phosphate dehydrogenase and lactate dehydrogenase) are
represented in Figs 1, 2 and 3. Diabetic animals treated with
500 mg kg 1 of the alcoholic extract of C. fenestratum showed
better enzyme activity than those treated with the lower
(250 mg kg 1) dose of the alcoholic extract. The significant
increase in the levels of hexokinase, a key glycolytic enzyme
known to decrease in the diabetic state (31), may be due to the
direct stimulation of glycolysis in tissues with increased
glucose removal from the blood. The significant reversal of
diabetes induced decreased levels of glucose-6-phosphate
dehydrogenase and lactate dehydrogenase may be attributed to
an increase in glucose utilization through the pentose phos-
phate pathway (32), interfering with the mitochondrial respira-
tory chain and promoting the peripheral glucose utilization by
enhancing anaerobic glycolysis (33).
Treated groups exhibited a significant decrease in the levels
of glucose-6-phosphatase (Fig. 4) and alanine amino transferase
(Fig. 5). Glucose-6-phosphatase, a key enzyme in gluconeoge-
nesis, plays an important role in glucose homeostasis in the
liver and kidney (34). The decreased levels observed in treated
diabetic animals may be because of the suppression of hepatic
gluconeogenesis and glucose output from liver. The elevation in
alanine amino transferase in liver and kidney observed in strep-
tozotocin induced diabetic rats corroborates earlier findings
(35,36) which attribute the increased gluconeogenesis and keto-
genesis observed in diabetes to the high activity of transami-
nases. In our study, supplementation with the alcoholic extract
decreased the enhanced transaminase activity significantly.
Serum urea (Fig. 6) and creatinine levels (Fig. 7) were also
decreased significantly compared with the diabetic control.
Antioxidant Status
Enzymatic Antioxidants
Antioxidants are of two types: enzymatic and nonenzymatic
antioxidants. Catalase, superoxide dismutase, peroxidase,
glutathione synthetase and glutathione peroxidase are examples
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Figure 3. Alcoholic extract of C. fenestratum significantly increases lactate
dehydrogenase levels in diabetic rats. Each value represents mean   SE,
n   6; a, statistical significance versus control (P   0.05); b, statistical
significance versus normal (P   0.05); U,  mol conversion of NAD to NADH
per minute.
0
5
10
15
20
25
30
35
40
Normal  Diabetic
control
 Alc.Ext
(250mg/kg)
 Alc.Ext
(500mg/kg)
Groups
U
/
g
/
m
i
n
Liver
Kidney
a,b
a,b
a,b
a,b
Figure 4. Alcoholic extract of C. fenestratum significantly decreases glucose-
6-phosphatase levels in diabetic rats. Each value represents mean   SE,
n   6; a, statistical significance versus control (P   0.05); b, statistical signif-
icance versus normal (P   0.05); U,  mol conversion of glucose-6-phosphate
to glucose.
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Figure 5. Alcoholic extract of C. fenestratum significantly decreases alanine
amino transferase levels in diabetic rats. Each value represents mean   SE,
n   6; a, statistical significance versus control (P   0.05); b, statistical
significance versus normal (P   0.05); U,  mol conversion of NADH to NAD
per minute.
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Figure 6. Alcoholic extract of C. fenestratum significantly decreases urea
levels in diabetic rats. Each value represents mean   SE, n   6; a, statistical
significance versus control (P   0.05); b, statistical significance versus
normal (P   0.05).
neh099.qxd  22/08/2005  12:37  Page 378of enzymatic antioxidants. Superoxide dismutase and catalase
are considered primary enzymes since they are involved in the
direct elimination of reactive oxygen species (37). Superoxide
dismutase is an important defense enzyme which catalyzes
the dismutation of superoxide radicals (38), and catalase is
a hemoprotein which catalyzes the reduction of hydrogen
peroxides and protects tissues from highly reactive hydroxyl
radicals (39). The reduced activity of superoxide dismutase
and catalase in the liver and kidney observed during diabetes
may result in deleterious effects as a result of the accumulation
of superoxide anion radicals and hydrogen peroxide (40).
Glutathione synthetase, the most important biomolecule pro-
tecting against chemical induced toxicity, participates in the
elimination of reactive intermediates by reduction of hydroper-
oxide in the presence of glutathione peroxidase (41,42). The
decreased level of glutathione synthetase observed in the
diabetic animals represents increased utilization resulting from
oxidative stress (43). Glutathione peroxidase, a selenium-
containing enzyme present in significant concentrations, detoxi-
fies H2O2 to H2O through the oxidation of reduced glutathione
(44). Depression of glutathione peroxidase activity, observed
in diabetic liver and kidney, has been shown to be an important
adaptive response to increased peroxidative stress (45). The
activity of enzymatic antioxidants [catalase, glutathione
peroxidase, glutathione synthetase, peroxidase and superoxide
dismutase (Figs 8–12)] increased significantly in extract-treated
animals (P   0.05).
Nonenzymatic Antioxidants
Tocopherol, ceruloplasmin and ascorbic acid are nonenzy-
matic antioxidants. Whereas  -tocopherol reduces lipid
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Figure 7. Alcoholic extract of C. fenestratum significantly decreases creatinine
levels in diabetic rats. Each value represents mean   SE, n   6; a, statistical
significance versus control (P   0.05); b, statistical significance versus
normal (P   0.05).
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Figure 8. Alcoholic extract of C. fenestratum significantly increases catalase
levels in diabetic rats. Each value represents mean   SE, n   6; a, statistical
significance versus control (P   0.05); b, statistical significance versus
normal (P   0.05); U,  mol of hydrogen peroxide consumed per minute.
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Figure 9. Alcoholic extract of C. fenestratum significantly increases
glutathione peroxidase levels in diabetic rats. Each value represents
mean   SE, n   6; a, statistical significance versus control (P   0.05); b,
statistical significance versus normal (P   0.05); U,  mol of glutathione
consumed per minute.
0
1
2
3
4
5
6
7
Normal  Diabetic
control
 Alc.Ext
(250mg/kg)
 Alc.Ext
(500mg/kg)
Groups
U
/
g
/
m
i
n
Liver
Kidney
a,b a,b
a,b
b
Figure 10. Alcoholic extract of C. fenestratum significantly increases
glutathione synthetase levels in diabetic rats. Each value represents
mean   SE, n   6; a, statistical significance versus control (P   0.05); b,
statistical significance versus normal (P   0.05); U,  mol of 1-Chloro-2,
4-dinitro benzene (CDNB)–glutathione synthetase conjugate formed per minute.
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Figure 11. Alcoholic extract of C. fenestratum significantly increases peroxi-
dase levels in diabetic rats. Each value represents mean   SE, n   6; a,
statistical significance versus control (P   0.05); b, statistical significance ver-
sus normal (P   0.05); U,  mol of hydrogen peroxide consumed per minute.
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and protects cell structures against damage (46), the powerful
nonenzymatic antioxidant ceruloplasmin inhibits lipid peroxi-
dation by binding to copper (47). Vitamin C or ascorbic acid is
an excellent hydrophilic antioxidant in plasma and disappears
faster than other antioxidants on exposure to reactive oxygen
species (48). The decreased level of ascorbic acid in diabetic
rats may be due either to increased utilization as an antioxidant
defense against increased reactive oxygen species or to a
decrease in glutathione level, since glutathione is required for
the recycling of ascorbic acid (49,50). The effect of treatment
with  C. fenestratum on the nonenzymatic antioxidants
tocopherol, ceruloplasmin and ascorbic acid is presented in
Figs 13, 14 and 15.
In our investigations, the levels of both enzymatic and
nonenzymatic antioxidants, which declined in the diabetic ani-
mals, were significantly restored on treatment with the alco-
holic extract. The overexpression of these antioxidant
parameters in diabetic rats treated with C. fenestratum implies
that this potential oxidant defense is reactivated by the active
principles of C. fenestratum, with an increase in the capacity
for detoxification through enhanced scavenging of oxy radicals.
The tetrahydro protoberberine analogue of berberine has been
reported to inhibit lipid peroxidation and to scavenge hydroxyl
free radicals (51). Preliminary phytochemical screening of
C. fenestratum showed the presence of phenolic compounds
(11), which have been reported to have antioxidant activity
(52). Hence in our study the antioxidant activity of C. fenes-
tratum may be due to the presence of berberine and phenolic
compounds.
The present investigation draws out a sequential metabolic
correlation between increased glycolysis and decreased
gluconeogenesis stimulated by C. fenestratum, which may
have been the biochemical mechanism through which glucose
homeostasis was regulated. The enhanced effect and the
protective action on cellular antioxidant defense of C. fenes-
tratum suggest protection against oxidative damage in strepto-
zotocin–nicotinamide induced diabetes.
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